arrow
J

Jiří Bronský

motol and homolka university hospital
H指数:51
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparison of risankizumab and upadacitinib treatment persistence according to disease location in patients with Crohn’s disease: data from the CREdIT registry

根据疾病位置的克罗恩病患者瑞萨基珠单抗和乌帕替尼治疗持续性的比较:CREdIT登记研究数据

2026-10-280
OAAI
Management of Pediatric Crohn’s Disease: an ECCO-ESPGHAN Guideline Update

儿科克罗恩病的治疗:ECCO-ESPGHAN指南更新

2026-08-190
OAAI
Persistence of advanced therapies in patients with ulcerative colitis: real-world data from the nationwide CREdIT registry

炎症性肠病溃疡性结肠炎患者中先进疗法的持续性:全国CREdIT注册研究中的真实世界数据

2026-03-300
OA
STEP-CD study: ustekinumab use in paediatric Crohn's disease-a multicentre retrospective study from paediatric IBD Porto group of ESPGHAN
2024-05-034
PRE
Faecal Bacteriome and Metabolome Profiles Associated with Decreased Mucosal Inflammatory Activity Upon Anti-TNF Therapy in Paediatric Crohn's Disease
2023-08-013
OAAI
Diagnosis of fatty liver in children should occur in parallel to investigation for other causes of liver disease

儿童脂肪肝的诊断应与肝病的其他原因的调查同时进行

2023-07-0114
PRE
Thromboprophylaxis Use in Paediatric Inflammatory Bowel Disease: An International RAND Appropriateness Panel

血栓预防在小儿炎症性肠病中的应用: 国际兰德适当性小组

2022-05-244
OAAI
Predicting Outcomes in Pediatric Crohn's Disease for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease-Ahead Program
2021-01-0163
OA
Predicting Outcomes in Pediatric Ulcerative Colitis for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease-Ahead Program
2021-01-0132
OAAI